Analgesia by Sacral Surface Electrical Stimulation for Primary Dysmenorrhoea

Mieko Yokozuka, Mayumi Nagai, Rieko Katsura, Kayoko Kenmyo, Mieko Yokozuka, Mayumi Nagai, Rieko Katsura, Kayoko Kenmyo

Abstract

Objective: To evaluate the effects of analgesia by sacral surface electrical stimulation on lower abdominal pain in women with primary dysmenorrhoea.

Design: Explorative study.

Participants: Eleven female university students, who regularly experience difficulty in their university work due to menstrual pain, or who use analgesics for more than one day each month, were recruited.

Methods: Sacral surface electrical stimulation, 5 Hz for 15 min, was performed after the onset of menstruation. Electrodes were placed on the skin, directly above the second and fourth sacral foramina. Visual analogue scale and degree of pain (calculated by using a low current to assess pain) were determined before and after electrical stimulation.

Results: Visual analogue scale score and degree of pain decreased significantly immediately after electrical stimulation (p < 0.001). A correlation was observed between visual analogue scale score and degree of pain before and after electrical stimulation (r=0.516, p <0.001). No side-effects were observed in any participant.

Conclusion: Sacral surface electrical stimulation may provide immediate pain relief in women with dysmenorrhoea and lower abdominal pain.

Keywords: analgesia; dysmenorrhoea; pain; sacral surface electrical stimulation.

Conflict of interest statement

The authors have no conflicts of interest to declare.

Journal Compilation © 2020 Foundation of Rehabilitation Information.

Figures

Fig. 1
Fig. 1
Flow chart of participant recruitment.
Fig. 2
Fig. 2
Correlation between visual analogue score (VAS) and degree of pain for lower abdominal pain in primary dysmenorrhoea. Before electrical stimulation (ES) (white circle); after ES (grey circle). Correlation between VAS and degree of pain (r = 0.516, β = 0.013, p< 0.001).

References

    1. Proctor M, Farquhar C. Diagnosis and management of dys-menorrhoea. BMJ 2006; 332: 1134-1138.
    1. Latthe PM, Champaneria R, Khan KS. Dysmenorrhoea. BMJ Clin Evid 2011; 21: pii: 0813.
    1. Dawood MY, Ramos J. Transcutaneous electrical nerve stimulation (TENS) for the treatment of primary dysmenorrhea: a randomized crossover comparison with placebo TENS and ibuprofen. Obstet Gynecol 1990; 75: 656-660.
    1. Nakagawa A, Sakaguchi A, Harada K, Kawaguchi K, Fujioka H. [Effect of transcutaneous electrical nerve stimulation (TENS) for relieving menstrual pain in healthy adult women.] J Jpn Phy Ther Assoc 2017; 44: 272-276 (in Japanese).
    1. Lauretti GR, Oliveira R, Parada F, Mattos AL. The new portable transcutaneous electrical nerve stimulation device was efficacious in the control of primary dysmenorrhea cramp pain. Neuromodulation 2015; 18: 522-527.
    1. Kaplan B, Peled Y, Pardo J, Rabinerson D, Hirsh M, Ovadia J, et al. . Transcutaneous electrical nerve stimulation (TENS) as a relief for dysmenorrhea. Clin Exp Obstet Gynecol 1994; 21: 87-90.
    1. Kaplan B, Rabinerson D, Lurie S, Peled Y, Royburt M, Neri A. Clinical evaluation of a new model of a transcutaneous electrical nerve stimulation device for the management of primary dysmenorrhea. Gynecol Obstet Invest 1997; 44: 255-259.
    1. Lee B, Hong SH, Kim K, Kang WC, No JH, Lee JR, et al. . Efficacy of the device combining high-frequency transcutaneous electrical nerve stimulation and thermotherapy for relieving primary dysmenorrhea: a randomized, singleblind, placebo-controlled trial. Eur J Obstet Gynecol Reprod Biol 2015; 194: 58-63.
    1. Wang SF, Lee JP, Hwa HL. Effect of transcutaneous electrical nerve stimulation on primary dysmenorrhea. Neuromodulation 2009; 12: 302-309.
    1. Tugay N, Akbayrak T, Demirtürk F, Karakaya IC, Kocaacar O, Tugay U, et al. . Effectiveness of transcutaneous electrical nerve stimulation and interferential current in primary dysmenorrhea. Pain Med 2007; 8: 295-300.
    1. Lundeberg T, Bondesson L, Lundström V. Relief of primary dysmenorrhea by transcutaneous electrical nerve stimulation. Acta Obstet Gynecol Scand 1985; 64: 491-497.
    1. Ogura T, Murakami T, Ozawa Y, Seki K, Handa Y. Magnetic resonance imaging of morphological and functional changes of the uterus induced by sacral surface electrical stimulation. Tohoku J Exp Med 2006; 208: 65-73.
    1. Fujii O, Murakami T, Murakawa H, Terada Y, Ogura T, Yaegashi N. Uterine relaxation by sacral surface electrical stimulation on the day of embryo transfer. Fertil Steril 2008; 90: 1240-1242.
    1. Fujii M, Nishie H, Mizobuchi S, Goto K, Morimatsu H. [Assessment of analgesic effect of intravenous lidocaine in the treatment of neuropathic pain using Pain Vision®, a quantitative pain measurement system.] J Japan Soc Pain Clin 2014; 21: 124-128 (in Japanese).
    1. Matsuoka T, Yoshida Y, Aisu N, Yamada T, Mogi A, Komono A, et al. . Evaluation of vascular pain in patients with colorectal cancer receiving peripheral venous chemotherapy with or without oxaliplatin. Sci Rep 2019; 9: 1819.
    1. Yoshida Y, Mogi A, Yamada T, Aisu N, Matsuoka T, Kojima D, et al. . Subjective and objective assessment of oxaliplatin- induced peripheral neuropathy. Springerplus 2015; 4: 822.
    1. Wang D, Zhang K, Han S, Yu L. PainVision® apparatus for assessment of efficacy of pulsed radiofrequency combined with pharmacological therapy in the treatment of postherpetic neuralgia and correlations with measurements. Biomed Res Int 2017; 2017: 5670219.
    1. Ohtori S, Kawaguchi H, Takebayashi T, Orita S, Inoue G, Yamauchi K, et al. . PainVision apparatus is effective for assessing low back pain. Asian Spine J 2014; 8: 793-798.
    1. Kim J, Lee KS, Kong SW, Kim T, Kim MJ, Park SB, et al. . Correlations between electrically quantified pain degree, subjectively assessed visual analogue scale, and the McGill pain questionnaire: a pilot study. Ann Rehabil Med 2014; 38: 665-672.
    1. Harada T, Momoeda M, Taketani Y, Hoshiai H, Terakawa N. Low-dose oral contraceptive pill for dysmenorrhea associated with endometriosis: a placebo-controlled, double-blind, randomized trial. Fertil Steril 2008; 90: 1583-1588.
    1. Ryan SA. The treatment of dysmenorrhea. Pediatr Clin North Am 2017; 64: 331-342.
    1. Milsom I, Hedner N, Mannheimer C. A comparative study of the effect of high-intensity transcutaneous nerve stimulation and oral naproxen on intrauterine pressure and menstrual pain in patients with primary dysmenorrhea. Am J Obstet Gynecol 1994; 170: 123-129.
    1. Proctor ML, Smith CA, Farquhar CM, Stones RW. Transcutaneous electrical nerve stimulation and acupuncture for primary dysmenorrhoea. Cochrane Database Syst Rev 2002; CD002123.
    1. Kalra A, Urban MO, Sluka KA. Blockade of opioid receptors in rostral ventral medulla prevents antihyperalgesia produced by transcutaneous electrical nerve stimulation (TENS). J Pharmacol Exp Ther 2001; 298: 257-263.
    1. Hamza MA, White PF, Ahmed HE, Ghoname EA. Effect of the frequency of transcutaneous electrical nerve stimulation on the postoperative opioid analgesic requirement and recovery profile. Anesthesiology 1999; 91: 1232-1238.
    1. Bai HY, Bai HY, Yang ZQ. Effect of transcutaneous electrical nerve stimulation therapy for the treatment of primary dysmenorrhea. Medicine 2017; 96: e7959.
    1. Yokozuka M, Namima T, Nakagawa H, Ichie M, Handa Y. Effects and indications of sacral surface therapeutic electrical stimulation in refractory urinary incontinence. Clin Rehabil 2004; 18: 899-907.

Source: PubMed

Sponsorer og samarbeidspartnere

Medisinsk tilstand

Legemiddelintervensjoner

3
Abonnere